GUNAR K ZAGARS to Survival Rate
This is a "connection" page, showing publications GUNAR K ZAGARS has written about Survival Rate.
Connection Strength
0.332
-
Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1124-9.
Score: 0.027
-
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):739-47.
Score: 0.022
-
Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):384-91.
Score: 0.019
-
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. 2001 Aug; 58(2):233-9.
Score: 0.019
-
Malignant Peripheral Nerve Sheath Tumors: A Single Institution's Experience Using Combined Surgery and Radiation Therapy. Am J Clin Oncol. 2018 05; 41(5):465-470.
Score: 0.015
-
External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? Urology. 1998 Feb; 51(2):258-64.
Score: 0.015
-
Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation. Cancer. 1997 Aug 15; 80(4):764-75.
Score: 0.014
-
Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996 Sep 01; 36(2):311-9.
Score: 0.013
-
Radiotherapy for stage T3b transitional cell carcinoma of the bladder. Semin Urol Oncol. 1996 May; 14(2):86-95.
Score: 0.013
-
Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):983-94.
Score: 0.013
-
Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):158-65.
Score: 0.012
-
Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology. 1995 Mar; 45(3):476-83.
Score: 0.012
-
Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. J Urol. 1994 Nov; 152(5 Pt 2):1786-91.
Score: 0.012
-
Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol. 1994 Oct; 33(1):23-30.
Score: 0.012
-
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy. Cancer. 1994 Apr 01; 73(7):1904-12.
Score: 0.011
-
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer. 1993 Sep 01; 72(5):1709-25.
Score: 0.011
-
Treatment of seminoma arising in cryptorchid testes. Int J Radiat Oncol Biol Phys. 1992; 24(1):153-9.
Score: 0.010
-
Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol. 1990 Jan; 143(1):37-40.
Score: 0.008
-
Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy. Cancer. 2008 Jul 15; 113(2):411-8.
Score: 0.008
-
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007 Oct; 246(4):675-81; discussion 681-2.
Score: 0.007
-
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 01; 70(3):760-5.
Score: 0.007
-
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1173-80.
Score: 0.007
-
Periosteal margin in soft-tissue sarcoma. Cancer. 2007 Feb 01; 109(3):598-602.
Score: 0.007
-
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006 Sep; 13(9):1209-15.
Score: 0.007
-
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.
Score: 0.006
-
Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002 Jul 15; 95(2):377-88.
Score: 0.005
-
Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):964-72.
Score: 0.005
-
Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct; 166(4):1306-10.
Score: 0.005
-
Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):891-905.
Score: 0.003
-
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. Urology. 1994 Nov; 44(5):711-8.
Score: 0.003
-
Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):267-77.
Score: 0.003
-
The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1383-8.
Score: 0.002
-
Radiation therapy of stage C prostate cancer: significance of Gleason grade to survival. Semin Urol. 1990 Nov; 8(4):225-31.
Score: 0.002